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HNAK is a ubiquitously expressed giant phos-
phoprotein  that was initially identiﬁed as a gene
product subject to transcriptional repression in neuro-
blastoma. AHNAK is predominantly nuclear in cells of
nonepithelial origin, but is cytoplasmic or associated with
plasma membrane in epithelial cells. In this study we show
that the extranuclear localization of AHNAK in epithelial
cells depends on the formation of cell–cell contacts. We
show that AHNAK is a phosphorylation substrate of protein
A
 
kinase B (PKB) in vitro and in vivo. Nuclear exclusion of
AHNAK is mediated through a nuclear export signal (NES) in
a manner that depends on the phosphorylation of serine
5535 of AHNAK by PKB, a process that also plays a major
role in determining extranuclear localization of AHNAK.
AHNAK is a new PKB substrate whose function, though
unknown, is likely to be regulated by its localization,
which is in turn regulated by PKB.
 
Introduction
 
AHNAK was first identified as a gene whose transcription is
repressed in cell lines of neuroblastoma and some other
tumors (Shtivelman et al., 1992). AHNAK is a protein of
an exceptionally large size (700 kD) that is encoded by an
intronless gene on chromosome 11q23 (Shtivelman et al.,
 
1992; Kudoh et al., 1995). AHNAK protein has three
structural domains: a relatively short NH
 
2
 
 terminus of 251
amino acids, a large central domain of 4,392 amino acids
composed entirely of highly conserved repeated elements, and
a unique COOH terminus of 1,000 amino acids (Shtivelman
et al., 1992). The central domain contains 39 conserved re-
peated elements, most of which are 128 amino acids in
length but many contain internal “deletions.” In turn, these
repeats display a recurrent motif of seven amino acids marked
by central proline residue and alternating hydrophilic and
hydrophobic residues. Structurally, this sequence resembles
a 
 
 
 
-strand with a periodicity of 2.33. This model predicts
a polyionic rod with hydrophobic residues facing inward
and charged residues facing outward, resulting in clear
separation of the hydrophobic and hydrophilic residues
(Shtivelman et al., 1992).
Expression of AHNAK RNA and protein is regulated in a
cell cycle–dependent manner. The highest levels of both
RNA and protein are observed in the G1 or G0 phase of the
cell cycle and are decreased in proliferating cells (Shtivelman
and Bishop, 1993). At the same time, total phosphorylation
of AHNAK in quiescent cells such as serum-starved fibroblasts
is dramatically diminished (Shtivelman and Bishop, 1993).
Neuroblastoma cells express low levels of highly phosphory-
lated AHNAK, but upon treatment with retinoic acid that
induces gradual growth arrest and terminal differentiation
levels of both AHNAK RNA and protein are increased,
whereas phosphorylation of AHNAK is significantly reduced
(Shtivelman and Bishop, 1993). These results indicate that
high levels of unphosphorylated AHNAK might be required
in the G1 phase, perhaps contributing to the maintenance of
the quiescent state. Alternatively, the phosphorylated form
of AHNAK might perform some cell division–related
function and might be rendered inactive by dephosphory-
lation. Phosphoamino acid analysis showed that AHNAK is
phosphorylated on serine and threonine residues (Shtivelman
and Bishop, 1993).
We first described subcellular localization of AHNAK to
be restricted mostly to cell nuclei and Golgi apparatuses of
nonepithelial cells (Shtivelman et al., 1992). Later, AHNAK
was identified independently as a protein associated with
the plasma membrane in epithelial cells (Hashimoto et al.,
1993; Masunaga et al., 1995). At low Ca
 
2
 
 
 
 concentrations
AHNAK assumes cytoplasmic localization, but an increase
in extracellular calcium results in translocation of AHNAK
to the plasma membrane (Hashimoto et al., 1995). The
COOH terminus of AHNAK was shown recently to be
responsible for subcellular localization of AHNAK (Nie
et al., 2000).
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Recent reports from other laboratories indicate that AH-
NAK might play a role in signal transduction. AHNAK
was identified as a protein that binds and activates phos-
pholipase C-
 
 
 
 in the presence of arachidonic acid (Sekiya
et al., 1999). In cardiomyocytes, AHNAK associates with
the 
 
 
 
2 subunit of the cardiac 
 
L
 
-type calcium channel
(Haase et al., 1999). Recently, AHNAK was shown to bind
S100b, a calcium- and zinc-binding protein (Gentil et al.,
2001) in a Ca
 
2
 
 
 
-dependent manner. Transcription of AH-
NAK is subject to strong downregulation by transforming
Ras alleles in rodent fibroblasts (Zuber et al., 2000), which
might be related to the elevated levels of AHNAK in rest-
ing cells as we described previously (Shtivelman and Bishop,
1993).
Protein kinase B (PKB)* is a member of the second messen-
ger-regulated subfamily of protein kinases implicated in sig-
naling downstream of growth factor and insulin receptor tyro-
sine kinases and of phosphatidylinositol 3-kinase (PI 3-kinase).
PKB is probably best known for its critical role in cell survival
pathways in response to a variety of apoptotic factors, though
the downstream targets of this enzyme are far from being fully
explored (Downward, 1998; Datta et al., 1999).
PKB activation occurs after stimulation with growth and
survival factors, by extracellular stimuli such as cell–matrix
and cell–cell contacts, and in response to hypoxia (for re-
view see Downward, 1998; Vanhaesebroeck and Alessi,
2000). Activation of PKB is initiated by the binding of 3
 
 
 
-
phosphorylated phosphoinositide products of PI 3-kinase
(PI 3,4,5-triphosphate and PI 3,4-biphosphate) to the
pleckstrin homology (PH) domain. This binding results in
targeting of PKB to the plasma membrane and activating
phosphorylation of threonine 308 and serine 473 by other
kinases such as proline-directed kinase PDK-1 (Vanhaese-
broeck and Alessi, 2000). Activated PKB was shown to be
responsible for survival signals transduced by PI 3-kinase in
the context of several model systems for apoptosis (Kandel
and Hay, 1999).
PKB activation has numerous consequences, affecting
transcription, protein synthesis, glucose metabolism, apop-
tosis, and the cell cycle (Downward, 1998; Meier and Hem-
mings, 1999). However, the signal transduction pathways
downstream of PKB activation are still being unraveled. Ac-
tivated PKB directly phosphorylates Bad (del Peso et al.,
1997), caspase 9 (Cardone et al., 1998), IKK-
 
 
 
 (Ozes et al.,
1999; Romashkova and Makarov, 1999), and apoptosis sig-
nal-regulating kinase ASK1 (Kim et al., 2001), promoting
cell survival. PKB phosphorylates several nuclear targets and
is itself capable of nuclear translocation upon growth factor
stimulation (Andjelkovic et al., 1997; Meier et al., 1997;
Borgatti et al., 2000). The most studied nuclear targets are
forkhead transcription factors (Biggs et al., 1999; Brunet et
al., 1999; Kops et al., 1999; Rena et al., 1999). Phosphory-
lation of AFX, FKHR, and FKHRL1 leads to their nuclear
exclusion and inhibition of transcriptional activity, resulting
in inhibition of apoptosis and/or stimulation of prolifera-
tion. Recently, cell cycle inhibitor p21 was shown to be di-
rectly phosphorylated by PKB (Zhou et al., 2001), with re-
sulting cytoplasmic sequestration of p21 and inhibition of
its antiproliferative activity.
In this study we show that AHNAK is a new direct target
of PKB phosphorylation in vitro and in vivo, and that phos-
phorylation of AHNAK by PKB contributes to nuclear ex-
clusion of AHNAK in epithelial cells.
 
Results
 
AHNAK is a phosphorylation substrate of PKB in vitro
 
Examination of the amino acid sequence of AHNAK re-
vealed the presence of a single consensus phosphorylation
site for PKB surrounding serine residue 5535 (RHRSNSF)
in the COOH-terminal domain of AHNAK. We have ex-
amined the functionality of the putative PKB phosphoryla-
tion site at serine 5535 in the in vitro phosphorylation as-
says. Three glutathione 
 
S
 
-transferase (GST)–AHNAK fusion
polypeptides were produced and purified from bacteria to
test as PKB substrates. GST–C213 encompassed the last
213 amino acids of AHNAK (between positions 5431 and
5643), including the PKB consensus phosphorylation site
at 5535. In GST–C213S/A serine 5535, the hypothetical
phosphorylation target of PKB was converted to an alanine.
The third GST fusion (GST–M466) contained 466 amino
acids from the middle domain of AHNAK, encompassing
three and a half AHNAK repeats that contain multiple PKC
and casein kinase II consensus phosphorylation sites but no
PKB consensus sites (unpublished data). These polypeptides
and the GST–Bad fusion polypeptide (positive control for
PKB phosphorylation) were used in the in vitro kinase assays
with active PKB purified from insect cells. Out of the three
GST–AHNAK polypeptides only GST–C213 was phos-
phorylated in vitro; substitution of serine to alanine in GST–
S/A completely abolished the appearance of a phosphory-
lated band (Fig. 1). The unrelated AHNAK polypeptide
GST–M466 was not phosphorylated either. These results
show that serine 5535 of AHNAK functions as an in vitro
substrate of PKB.
 
*Abbreviations used in this paper: caPKB, constitutively active PKB;
EGFP, enhanced GFP;
 
 
 
GFP, green fluorescent protein; GST, glu-
tathione 
 
S
 
-transferase;
 
 
 
LMB, leptomycin B; MAGUK, membrane-associ-
ated guanylate kinase; NES, nuclear export signal; NLS, nuclear localiza-
tion signal; PH, pleckstrin homology;
 
 
 
PI 3-kinase, phosphatidylinositol
3-kinase;
 
 
 
PKB, protein kinase B.
Figure 1.  AHNAK is a phosphorylation substrate of PKB in vitro. 
Purified PKB was tested with the GST fusion proteins indicated as 
described in the Materials and methods. GST–Bad served as a 
positive control for phosphorylation and GST as a negative control. 
GST–C213 contains the last 213 amino acids of AHNAK fused to 
GST. The S/A construct contains a substitution of serine to alanine 
within the PKB consensus site. GST–M466 contains part of the 
AHNAK middle domain consisting of four repeats. 
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PKB activity is increased in densely growing HeLa cells 
and correlates with the nuclear export of AHNAK
 
We have shown previously that AHNAK is a predominantly
nuclear protein in different cultured cells of nonepithelial
origin by subcellular fractionation and immunofluorescent
staining (Shtivelman and Bishop, 1993). However, a plasma
membrane localization of AHNAK was reported in epithe-
lial cells (Hashimoto et al., 1993, 1995). We have per-
formed immunofluorescent staining of endogenous AH-
NAK in a HeLa cervical carcinoma cell line. In freshly plated
cultures of HeLa cells that have not reached high density,
AHNAK was found in the nuclei with a weak diffuse cyto-
plasmic staining (Fig. 2 A), confirming our previous obser-
vations. However, we have noticed that in dense cultures of
HeLa cells that have been plated for 
 
 
 
2 d, AHNAK assumes
mostly cytoplasmic localization (Fig. 2 A).
We have considered the possibility that redistribution of
AHNAK to the cytoplasm of dense HeLa cells is regulated
through phosphorylation by PKB. In addition to our data on
phosphorylation of AHNAK by PKB in vitro, several indirect
lines of evidence were supportive of this hypothesis: (1) the
COOH terminus of AHNAK (where the PKB consensus site
is located) is responsible for its subcellular localization (Nie et
al., 2000); (2) phosphorylation by PKB induces cytoplas-
mic sequestration of several known substrates, among them
FKHR (Biggs et al., 1999) and p21 (Zhou et al., 2001); and
(3) PKB is activated by the formation of cell–cell contacts
(Pece et al., 1999; Watton and Downward, 1999). Based on
these data we have examined a possible correlation between
PKB activity in HeLa cells and AHNAK localization. As
shown in Fig. 2 B, subconfluent HeLa cultures have relatively
low levels of active PKB, as detected by antibodies specifically
recognizing PKB phosphorylated on serine 473. Phosphoryla-
tion of PKB is fully inhibitable by treatment with the specific
PI 3-kinase inhibitor LY294002. Sparse cultures have barely
detectable levels of phosphorylated PKB; however, dense cul-
tures have much more activated PKB, whereas the total levels
of PKB protein remain constant under all conditions exam-
ined. These data show a correlation between the translocation
of AHNAK from nuclei to the cytoplasm and phosphoryla-
tion, and therefore activation of PKB.
 
Inhibition of PI 3-kinase activity leads to nuclear 
redistribution of AHNAK
 
Next, we examined the effect of inhibition of PKB activity
on localization of AHNAK. Cells were treated for different
lengths of time with LY294002 before immunofluorescent
staining. These experiments were performed with HeLa and
MDCK cells derived from immortalized canine kidney epi-
thelium. AHNAK was nuclear in freshly plated (24 h or less)
MDCK cells, but redistributed to plasma membrane in cul-
tures allowed to reach confluence for 48–72 h (Fig. 3).
When dense cultures of HeLa or MDCK cells were treated
with LY294002, AHNAK translocated to the nucleus from
either the cytoplasm of HeLa cells or from the plasma mem-
brane in MDCK cells (Fig. 3). The process of translocation
was rapid, with many cells demonstrating nuclear AHNAK
after just 15 min of incubation with LY294002 (unpublished
data), and the majority of cells contained nuclear AHNAK
after a 1-h incubation. These results indicate that phosphory-
Figure 2.  Relocalization of AHNAK to 
the cytoplasm in dense cultures correlates 
with an increase in PKB activity. (A) 
Sparsely growing (top) or dense (bottom) 
HeLa cells were stained for endogenous 
AHNAK with a polyclonal anti-AHNAK 
antiserum against the repeated domain 
described previously (Shtivelman and 
Bishop, 1993) and goat anti–rabbit Cy-3–
conjugated antibodies. (B) Extracts from 
HeLa cells grown at normal (subconfluent) 
density with or without LY294002 
treatment (30  M for 1 h), at low density 
(sparse), and confluent culture (dense) were 
subjected to Western blotting with an 
antibody specific to phosphoserine 473 of 
PKB (pS473-PKB) to detect activated PKB 
or antibody to PH domain (PH-PKB) to 
detect PKB protein.
Figure 3.  Localization of endogenous AHNAK in cells at different 
densities and nuclear translocation after inhibition of PI 3-kinase 
pathway. Cells were processed for indirect immunofluorescence 1 d 
after plating (sparse) or 3 d after plating (dense). Dense cultures were 
treated for the last 1 h before fixation with the PI 3-kinase inhibitor 
LY294002 at 30 mM. Cells were stained as described in the legend 
to Fig. 2. Treatment of sparse cultures with LY294002 did not affect 
localization of AHNAK (unpublished data). 
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lation by PKB might prevent nuclear translocation or medi-
ate nuclear exclusion of AHNAK.
 
AHNAK is phosphorylated by PKB in vivo and assumes 
predominantly extranuclear localization
 
The unusually large size of AHNAK and the presence of nu-
merous phosphorylation sites for a variety of kinases within
its sequence precluded phosphopeptide mapping as a means
of identification of the PKB-phosphorylated residue. To de-
termine whether PKB phosphorylates AHNAK in vivo,
we generated antisera to phosphopeptide containing serine
5535. Antibodies specifically recognizing AHNAK phos-
phopeptide containing phosphorylated serine 5535 were pu-
rified and their specificity was examined. Fig. 4 A shows that
purified phosphospecific antibodies specifically recognize an
exogenously expressed COOH-terminal polypeptide of AH-
NAK, but not a version that has serine 5535 mutated to an
alanine residue.
These phosphospecific antibodies were used to examine
the phosphorylation status of serine 5535 of the endogenous
AHNAK protein in MDCK and HeLa cells subjected to
treatment with LY294002. As seen in Fig. 4 B, the reactivity
of the purified phosphospecific antibodies with endogenous
AHNAK is greatly diminished upon treatment with PI
3-kinase inhibitor. An identical pattern was observed with
phosphospecific antibodies purified independently from two
additional immunized rabbits (unpublished data). As a con-
trol for the effect of LY294002, the activating phosphoryla-
Figure 4.  Characterization of phosphospecific antibodies against PKB-phosphorylated AHNAK and immunofluorescent detection of 
phosphorylated AHNAK. (A) Purified phosphospecific antibodies (pS5535-AHNAK) were used for Western blot analysis of HEK293 cells 
transiently transfected with two COOH-terminal expression constructs of AHNAK differing only in one amino acid residue; serine 5535 was 
either intact (wt) or substituted by alanine (S5535A). As a control, an identical Western blot was detected with antibody fraction from the 
same rabbit before immunoaffinity purification on phosphopeptide column. (B) Reactivity of phosphospecific antibodies with the endogenous 
AHNAK is greatly reduced in cells treated with LY294002. Western blot analysis of AHNAK was performed with cells extracts prepared 
before and after treatment with 30  M LY294002 for 1 h using purified phosphospecific antibodies. Antiserum against repeat region of 
AHNAK was used as a control for the total AHNAK protein levels (anti-AHNAK). Activity of PKB in cell extracts was monitored by anti-PKB 
antibodies as described in the legend to Fig. 2. (C) Western blot analysis of AHNAK phosphorylation on serine 5535 in MDCK neo (control) 
and caPKB clone expressing caPKB. Cells were either untreated or treated with 30  M LY294002 for 4 h. Blots were probed with antibodies 
indicated as in B. (D) Purified phosphospecific antibodies detect preferentially plasma membrane–associated AHNAK in dense MDCK cells 
but react only weakly with the nuclear AHNAK in cells treated for 1 h with LY294002. Inclusion of the immunizing phosphopeptide abolished 
reactivity of antibodies with cells (unpublished data). (E) Western blot analysis of AHNAK contents in subcellular fractions prepared from 
sparsely and densely growing cells. HeLa cells were fractionated into nuclear (N) and cytoplasmic (C) fractions by hypotonic lysis. Aliquots of 
fractions and total lysates (T) representing approximately equal cell numbers were subjected to electrophoresis and Western blotting with the 
indicated anti-AHNAK antibodies. 
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tion of PKB on serine 473 is shown to be inhibited in
LY294002-treated cells (Fig. 4 B).
To formally prove that AHNAK is indeed phosphorylated
specifically by PKB in vivo, we have stably introduced into
MDCK cells a constitutively active PKB (caPKB). This form
of PKB is not responsive to PI 3,4,5-triphosphate signaling
due to removal of the PH domain (Stokoe et al., 1997). In
addition, two residues that are phosphorylated in activated
PKB, serine 473 and threonine 308, were changed to aspar-
tates in order to mimic a constitutively phosphorylated ac-
tive form of the enzyme (Stokoe et al., 1997). Examination
of the activity of caPKB in control and caPKB-expressing
MDCK clones indeed showed that caPKB remains fully ac-
tive when cells are treated with LY294002 (unpublished
data). Phosphorylation of AHNAK was examined in control
MDCK clones and in caPKB-expressing clones with or
without LY294002 treatment. Fig. 4 C shows that phos-
phorylation of AHNAK is diminished in MDCKneo but
not in MDCK-caPKB cells in the presence of LY294002.
Thus, caPKB phosphorylates AHANK even when the entire
PI 3-kinase pathway is inhibited. This proves that PKB and
not another kinase is responsible for phosphorylating serine
55353 of AHNAK in vivo.
The anti–phosphoserine 5535 antibodies were used for
analysis of subcellular localization of PKB-phosphorylated
AHNAK. As shown in Fig. 4 C, these antibodies efficiently
detect the plasma membrane–localized AHNAK in dense
MDCK cells, confirming that AHNAK anchored at the
membrane is indeed phosphorylated by PKB. However, the
reactivity of the antibodies with the nuclear-localized AHNAK
in LY294002-treated cells is greatly reduced (compare Fig. 3
with Fig. 4 D). Similarly, the phosphospecific antibodies ef-
ficiently recognize the cytoplasmic AHNAK in dense HeLa
cells (unpublished data).
To confirm independently the results on nuclear exclu-
sion of PKB-phosphorylated AHNAK obtained through cell
staining, we have performed biochemical fractionation of
sparse and dense HeLa cultures. We examined the distribu-
tion of the total AHNAK protein versus the PKB-phosphor-
ylated pool of AHNAK in cell fractions. Fig. 4 E shows that
phosphoserine 5535–AHNAK is not found in the nuclei ir-
respective of cell density, not even in sparse cultures where
the bulk of AHNAK is nuclear. Thus, the fractionation re-
sults are in full agreement with the results of cell staining
with AHNAK antibodies.
 
The exogenously expressed COOH terminus of 
AHNAK assumes nuclear or cytoplasmic localization 
depending on the phosphorylation status 
of serine 5535
 
To directly demonstrate a role for PKB phosphorylation in
localization of AHNAK we examined localization of site-
specific AHNAK mutants affecting PKB site. We have
subcloned the COOH terminus of AHNAK into vector
pEGFP.C1 to create a fusion of the enhanced green fluores-
cent protein (EGFP) with the last 998 amino acids of AH-
NAK (EGFP-C998). Site-specific mutations of AHNAK
shown in Fig. 5 A were introduced into EGFP–C998.
Serine 5535 within PKB consensus site was changed ei-
ther to alanine to prevent phosphorylation by PKB (S/A) or
to aspartate to mimic constitutive phosphorylation (S/D).
In addition, we have substituted two lysine residues within
the sequence immediately adjacent to the PKB consensus
site by alanines (C998nls, Fig. 5). This was done in order to
examine the possibility that the basic cluster immediately
adjacent to PKB phosphorylation site might serve as a nu-
clear localization signal, though it must be noted that short
stretches rich in basic residues are encountered several times
within the COOH-terminal 998 amino acids of AHNAK
(Shtivelman et al., 1992). We were aware of the possibility
that changing the charge of one of these basic clusters
within the context of a polypeptide of 1,000 amino acids
might not necessarily affect its localization. However, the
proximity of this particular basic cluster to the PKB phos-
phorylation site prompted us to examine it in localization
studies. We have also prepared a green fluorescent protein
(GFP) fusion construct with the NH
 
2
 
-terminal domain of
AHNAK. A total of 949 NH
 
2
 
-terminal amino acids com-
posed of the unique 251 amino acids and the following five
Figure 5. Localization of the COOH-terminal domain of AHNAK 
fused to EGFP is regulated by the phosphorylation status of serine 
5535. (A) Amino acid sequence of the region of AHNAK around 
the PKB phosphorylation site and mutations introduced into it. 
(B) Localization of the EGFP–COOH-terminal AHNAK fusion 
proteins in transiently transfected HeLa cells. 
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“AHNAK repeats” were contained within encoded polypep-
tide (EGFP–N949).
Expression of the proteins of expected size from all con-
structs was confirmed by Western blotting (unpublished
data). Localization of EGFP–AHNAK fusions was examined
in transient expression assays with HeLa cells. The NH
 
2
 
 ter-
minus of AHNAK directed exclusively cytoplasmic localiza-
tion of EGFP (Fig. 5 B), demonstrating that signals regulat-
ing nuclear import of AHNAK are located within its COOH
terminus, in agreement with the previously published results
(Nie et al., 2000). The unaltered COOH terminus construct
and S/A mutant localized mostly to nuclei, whereas the S/D
and nuclear localization signal (NLS) mutants were predom-
inantly cytoplasmic, though some of the fluorescence was re-
tained in the nuclei of transfected cells (Fig. 5). The cytoplas-
mic localization of the C998nls mutant implies a functional
role of the basic cluster adjacent to PKB phosphorylation site
(Fig. 5 A) in directing nuclear import of AHNAK. The re-
sults obtained with the PKB site mutants provide a confir-
mation for the functional role of PKB phosphorylation in
regulating localization of AHNAK. It should be noted that
we had not observed a complete nuclear exclusion of AH-
NAK with either C998S/D or nls mutants. This implies that
the NH
 
2
 
 terminus or repeated middle domain of AHNAK
contributes to the extranuclear localization of AHNAK un-
der conditions of high cellular density. However, the ob-
served cytoplasmic localization of the C998S/D and C998nls
mutants confirmed our hypothesis about the key role of PKB
in regulating localization of AHNAK protein.
During the course of these experiments we have noticed
that expression of EGFP–AHNAK fusion proteins occurs at
very low levels and is extremely unstable, resulting in the dis-
appearance of the green fluorescence within 48 h after trans-
fection. This was more pronounced for the COOH-termi-
nal AHNAK fusions with cytoplasmic localization, which
were expressed at very low levels compared with nuclear lo-
calized polypeptides. Moreover, cells expressing the COOH-
terminal domain of AHNAK tended to be of a much larger
size on average than untransfected cells and frequently dis-
played enlarged, multilobular, or multiple nuclei. We have
never observed transfected cells undergoing normal mitosis
(unpublished data). These observations are very similar to
those of Nie et al. (2000), and suggest that expression of the
COOH terminus of AHNAK is incompatible with cell divi-
sion and/or survival.
 
Localization of the COOH-terminal EGFP–AHNAK 
fusion proteins is subject to regulation by cell density 
similar to that of endogenous AHNAK
 
To examine whether the COOH-terminal domain of AH-
NAK changes its localization depending on formation of
cell–cell contacts, we have performed transient transfection
experiments of dense cultures of HeLa cells. As shown in Fig.
6, we found that the EGFP–C998 fusion of COOH termi-
nus of AHNAK undergoes a change in subcellular localiza-
tion depending on culture density similar to that shown for
endogenous AHNAK. Whereas predominantly nuclear in
subconfluent cultures, it is found in cytoplasm of densely
plated cells (Fig. 6). However, neither of the two constructs
with alterations in the PKB phosphorylation site nor the
construct with a mutated NLS are capable of assuming a dif-
ferent localization depending on cell density (Fig. 6). The
S/A mutant that cannot be phosphorylated by PKB is mostly
retained in the nuclei of transfected cells, whereas the S/D
mutant mimicking constitutive phosphorylation and the
NLS mutant are retained in the cytoplasm independently of
cell density of transfected cultures (Fig. 6 B). These results
confirm that shuttling of AHNAK as a function of cell den-
sity is regulated at least partially through phosphorylation at
the PKB site and the adjacent nuclear localization signal.
Figure 6.  Localization of the COOH-terminal domain of AHNAK 
fused to EGFP is subject to regulation by cell density only when the 
PKB phosphorylation site is intact. (A) The indicated EGFP fusion 
constructs were transfected into dense HeLa cultures, plated for 2 d, 
and fixed 24 h later. (B) Quantitative analysis of the subcellular 
distribution of transfected COOH terminus of AHNAK in dense 
versus sparse HeLa cells. Experiments were performed at least three 
times with each construct and at least 200 fluorescent cells were 
counted per each experiment. White bars represent data obtained 
with cells plated at low density; gray bars represent data obtained 
with cells plated at high density. Error is expressed as a standard 
deviation of the mean values. 
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Phosphorylation of serine 5535 alone is not 
sufficient to prevent nuclear accumulation of 
the COOH terminus of AHNAK
 
To further analyze the specific role of phosphorylation by
PKB in nuclear exclusion of AHNAK, we have conducted
experiments aimed at determining the smallest domain of
AHNAK whose localization is still regulated by PKB. We
have constructed three additional EGFP–AHNAK fusion
constructs encoding progressively shorter COOH-termi-
nal fragments of AHNAK (Fig. 7). EGFP–C817 assumed
predominantly nuclear localization upon transfection into
sparsely plated cells, but in dense cells was found in cyto-
plasm of most cells (Fig. 7) behaving essentially as EGFP–
C998. Introduction of serine 5535 to aspartate substitution
into EGFP–C817 had the same effect on its localization as
on localization of the longer EGFP–C998 resulting in nu-
clear exclusion of most of the protein irrespective of cell den-
sity (Fig. 7). Two shorter EGFP fusion constructs were pre-
pared containing the last 575 and 213 amino acids of
AHNAK. Both of them produced polypeptides that were
overwhelmingly nuclear upon transfection into HeLa cells.
Density of transfected cells had no effect on the nuclear lo-
calization of shorter EGFP fusions (Fig. 7).
We have the nuclear-localized polypeptides produced
from EGFP–C575 and –213 to see whether they are phos-
phorylated by PKB on serine 5535. Extracts from transiently
transfected 293 cells were electrophoresed and blotted with
phosphospecific antibodies to phosphoserine 5535; both
polypeptides were found to be phosphorylated (unpublished
data). Moreover, introduction of serine 5535 to aspartate
substitution into EGFP–C575 and EGF–C213 did not pre-
vent nuclear accumulation of these polypeptides (unpub-
lished data). Because the molecular size of even the smaller
polypeptide 
 
 
 
50 kD, the possibility of free diffusion in and
out of the nucleus could be excluded. Apparently the
removal of the 236 amino acids between EGFP–C817
and –C575 results in nuclear retention of the remaining
COOH-terminal polypeptide, irrespective of the phosphor-
ylation status of serine 5535. This implies that nuclear ex-
clusion of PKB phosphorylated AHNAK relies on additional
signals provided by the amino acid sequence between posi-
tions 4826 and 5071. We have noticed also that removal of
that region resulted in significantly higher expression levels
of EGFP–AHNAK fusions in transfected cells as evaluated
by microscopy and Western blot analysis (unpublished data).
 
Identification of nuclear export signal in 
AHNAK sequence
 
Close inspection of the predicted amino acid sequence of AH-
NAK between positions 4826 and 5071 revealed the presence
of a leucine-rich sequence at positions 4875–4884 that fits the
consensus nuclear export signal (NES) sequence (Fornerod et
al., 1997; Henderson and Eleftheriou, 2000). We have exam-
ined the two fusion polypeptides (EGFP–C998 and –C817)
that contain this region to see whether they are responsive to
treatment with leptomycin B (LMB), a specific inhibitor of
nuclear export that is mediated in a CRM1-dependent man-
ner (Nishi et al., 1994; Fukuda et al., 1997). As shown in Fig.
Figure 7. The region in the COOH terminus of AHNAK between amino acids 4826 and 5068 is necessary for the extranuclear localization 
of AHNAK and might contain NES. (A) Localization of the indicated EGFP fusion constructs in transiently transfected HeLa cells 24 h after 
transfection. Cells shown in the right panels were treated with 20 ng/ml LMB for 1 h. (B) Quantitative analysis of the subcellular distribution 
of transfected AHNAK polypeptides in dense HeLa cells was performed as described in legend to Fig. 6. Gray bars represent localization in 
untreated dense cells; black bars represent cultures treated with LMB at 20 ng/ml for 1 h. 
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7, both polypeptides are retained in the nuclei of dense cul-
tures treated with LMB. However, an aspartate substitution of
serine 5355 in both fusion proteins prevented their nuclear
accumulation in response to treatment with LMB, indicating
that phosphorylation by PKB is involved in regulation of
CRM1-mediated nuclear export of AHNAK polypeptide.
To examine whether endogenous AHNAK is also subject
to CRM1-mediated nuclear export we have examined the lo-
calization of AHNAK in dense HeLa and MDCK cells
treated with LMB. Treatment of densely growing HeLa cells
with LMB resulted in nuclear redistribution of endogenous
AHNAK from a predominantly cytoplasmic localization (Fig.
8). Similarly, treatment of dense MDCK cells with LMB re-
sulted in the disappearance of the membrane-associated AH-
NAK and its nuclear translocation in majority of cells.
To verify the presence of NES between positions 4875 and
4884 in the AHNAK protein, fusion protein EGFP–C755
was generated spanning the COOH-terminal sequences of
AHNAK starting immediately after the putative NES at po-
sition 4887. This fusion protein was overwhelmingly nuclear
in both sparsely or densely growing HeLa cells (Fig. 9). Be-
cause localization of the EGFP–C817 was cytoplasmic in
densely growing cells and responsive to treatment with LMB,
whereas EGFP–C755 was nuclear under all conditions, the
possibility of a functional NES within the first 62 amino ac-
ids of C817 was further strengthened. To examine whether
constitutive phosphorylation of AHNAK at serine 5535
could interfere with nuclear localization of EGFP–C755, an
aspartate substitution was introduced into this construct.
EGFP–C755S/D was found predominantly in the nuclei of
transfected cells similar to shorter fusions EGFP–C581 and
C213 with serine 5535 to asparate substitution described
above (Fig. 9). This is compatible with the explanation that
the putative NES absent from EGFP–C755 is necessary for
the nuclear export of PKB-phosphorylated AHNAK.
To confirm the functionality of the leucine-rich sequence
at positions 4875–4884 as an NES, we have introduced po-
tentially disabling mutations by changing the key leucine
and isoleucine residues within it to alanines in both EGFP–
C998 and –C817 fusion proteins. The resulting polypep-
tides EGFP–C998nes and EGFP–C817nes showed a pre-
dominantly nuclear localization when transfected into dense
HeLa cells (Fig. 9) confirming that the stretch of amino ac-
ids between 4875 and 4884 serves as an NES.
 
Discussion
 
In this study we show that localization of AHNAK in epi-
thelial cells is subject to regulation by formation of cell–cell
contacts and that this regulation involves phosphorylation of
AHNAK by PKB. AHNAK is excluded from the nuclei of
dense cells by a mechanism involving CRM1-dependent nu-
clear export in a phosphorylation-dependent manner.
AHNAK is a protein that shuttles between different cellu-
lar compartments of epithelial cells in response to signals re-
ceived from the extracellular environment. It was shown pre-
viously that calcium concentration is one such signal and that
in low-calcium AHNAK translocates to the cytoplasm and
nucleus from its normal localization at the plasma membrane
of keratinocytes (Hashimoto et al., 1995). In this work we
have identified the formation of cell–cell contacts as a trigger
that provokes plasma membrane translocation of AHNAK
from its nuclear localization in isolated MDCK cells. Our
study was conducted with two cell lines of epithelial origins:
MDCK cells that are immortalized but preserve the differen-
tiation features of polarized epithelium, and HeLa cells de-
rived from a cervical carcinoma. Unlike MDCK, HeLa cells
could have lost many of the specialized cellular contact struc-
tures of the normal epithelium, and that could be the reason
for the lack of AHNAK association with the plasma mem-
brane of HeLa cells. Nevertheless, the mechanisms of the nu-
clear exclusion of AHNAK in dense cultures seem to be simi-
lar in MDCK and HeLa cells in that they are regulated by
PKB phosphorylation of AHNAK at serine 5535.
AHNAK phosphorylated by PKB is found predominantly
in the cytoplasm of HeLa cells or associated with the plasma
membrane of MDCK cells. In turn, inhibition of the PI
3-kinase pathway results in nuclear translocation of AHNAK
in both cell lines, similar to plating cells at low density. This
is unlikely to be a mere coincidence, as PKB was shown to be
activated by the formation of cell–cell contacts (Pece et al.,
1999; Watton and Downward, 1999) and we have indirectly
Figure 8.  Localization of endogenous AHNAK in HeLa and 
MDCK cells treated with LMB. Dense cultures either untreated or 
treated with LMB at 20 ng/ml for 5 h were stained for endogenous 
AHNAK with a polyclonal anti-AHNAK antiserum against the 
repeated domain. 
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confirmed these observations here by detecting a higher PKB
activity in confluent cultures of HeLa cells. Significantly,
PKB activation occurs rapidly in MDCK cells that are al-
lowed to form E-cadherin–mediated junctions by restoration
of calcium concentration in cultures treated with a calcium
chelator (Pece et al., 1999). PKB was reported to be activated
by an increase in calcium concentration via Ca
 
2
 
 
 
/calmodu-
lin–dependent protein kinase kinase in a PI 3-kinase–inde-
pendent manner (Yano et al., 1998). Calcium signaling was
previously implicated in the regulation of AHNAK localiza-
tion (Hashimoto et al., 1995) and this work shows a role for
PKB phosphorylation in the shuttling of AHNAK. Based on
these results, we suggest that AHNAK could be part of a sig-
nal transduction pathway initiated at the calcium- dependent
E-cadherin–mediated homophylic adhesion sites resulting in
activation of PKB, translocation of AHNAK, and a conse-
quent impact on cell survival and/or proliferation.
The region of AHNAK that regulates its localization was
shown to be contained within the COOH terminus of the
protein (Nie et al., 2000), but no known motives potentially
involved in this regulation have been identified before this
study. We show that in addition to the PKB phosphoryla-
tion site there is an NES that causes nuclear exclusion of the
phosphorylated COOH terminus of AHNAK. The phos-
phorylation by PKB is apparently a necessary prerequisite
for the nuclear export of AHNAK, because constitutively
unphosphorylated mutants of the serine 5535 encompassing
NES fail to be excluded from the nuclei of densely growing
cells. At the same time, removing or mutating NES results in
nuclear retention of the AHNAK COOH terminus irrespec-
tive of the phosphorylation status of serine 5535.
Two potential explanations are compatible with the re-
sults described here. First, phosphorylation by PKB retains
AHNAK in the cytoplasm or tethers it to plasma membrane
of epithelial cells, thus preventing nuclear import. The sec-
ond possibility is that AHNAK is continuously and maybe
constitutively imported into the nucleus, but phosphoryla-
tion of AHNAK by nuclear PKB facilitates its nuclear
export in a CRM1-dependent manner. Our results point to
the second explanation as a more plausible one because
COOH-terminal constructs of AHNAK constitutively phos-
phorylated on serine 5535 but lacking NES accumulate
within the nuclei of transfected cells, indicating that phos-
phorylated AHNAK is capable of nuclear import. The most
plausible scenario could be that AHNAK is nuclear in sparse
cells but formation of cell–cell contacts leads to activation of
PKB that translocates to the nucleus, phosphorylates AH-
NAK, and leads to its nuclear exclusion via the LMB-inhib-
itable pathway. To support this hypothesis, it has been
shown that activated endogenous PKB translocates to the
nucleus (Andjelkovic et al., 1997; Meier et al., 1997). In ad-
dition, phosphorylation of the transcription factor AFX and
the oncogene TCL1 by PKB was shown to occur in the cell
nucleus (Pekarsky et al., 2000; Brownawell et al., 2001).
Mechanisms of cytoplasmic retention of PKB-phosphory-
lated AHNAK remain unclear but are unlikely to involve
14-3-3 proteins because we could not detect binding of
AHNAK to 14-3-3 (unpublished data).
Figure 9.  The region between amino acids 4875 and 4884 serves as an NES. (A) Sequence of the putative NES in AHNAK. The amino acid 
residues substituted by alanine residues are in bold. (B) Removal of the putative NES or introduction of mutations into Leu 4879 and Ile 4882 
result in nuclear retention of AHNAK. Constructs were transfected into dense HeLa cells. (C) Quantitative analysis of the subcellular distribution 
of transfected AHNAK polypeptides in dense HeLa cells was performed as described in legend to Fig. 6. 
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Epithelial cell proliferation is subject to strict regulation
by extracellular signals provided by cell–cell contacts and
substrate adherence. Peripheral proteins that are positioned
strategically at sites of cell–cell or substrate adherence are
known to be involved in the integration of the extracellular
stimuli with the signal transduction mechanisms. Some-
times these proteins themselves are capable of traveling from
the plasma membrane to the nucleus, apparently fulfilling a
messenger function. There is now a growing list of proteins
that are associated with specialized cell–cell contacts such as
tight junctions, adherens junctions, and desmosomes, which
are capable of translocation to cell nuclei under certain de-
fined conditions or developmental stages. One of them is
ZO-1, a protein found in both tight and adherens junctions
that translocates to the nucleus in cells that have not yet
formed cell–cell contacts (Gottardi et al., 1996). ZO-1 is a
mammalian homologue of a 
 
Drosophila
 
 protein dlg, a tumor
suppressor (Woods and Bryant, 1991) and a “founding
member” of the membrane-associated guanylate kinase
(MAGUK) family of proteins. The MAGUK family mem-
bers share a common modular structure that invariably in-
cludes one or more PDZ domains (for review see Anderson,
1996). Another MAGUK, MAGI-1c, is also capable of
nuclear relocalization from cell cortex (Dobrosotskaya et al.,
1997). A protein named periaxin (Gillespie et al., 1994),
though not a member of MAGUK family, contains two
PDZ domains and is capable of nucleocytoplasmic shuttling
(Sherman and Brophy, 2000). Periaxin is found in the nu-
clei of embryonic Schwann cells but translocates to plasma
membrane processes of the myelinating Schwann cells (Gil-
lespie et al., 1994). Interestingly, periaxin is the only protein
in the database that shares a significant degree of homology
with the repeated domain of AHNAK (unpublished data
and Kingsley et al., 2001). Recent report indicates that ex-
pression and subcellular localization of AHNAK in embry-
onic tissues is subject to a dynamic developmental regulation
(Kingsley et al., 2001).
Another well known example of protein shuttling in epi-
thelial cells involves 
 
 
 
-catenin (for review see Polakis, 2000).
 
 
 
-Catenin binds to E-cadherin in the adherens junctions
complex (Orsulic et al., 1999) but translocates to the nu-
cleus upon activation of the Wnt signaling pathway. Nuclear
 
 
 
-catenin binds to and activates the LEF-1/TCF transcrip-
tion factors to induce expression of genes involved in tumor-
igenicity and invasion (Polakis, 2000). The mechanisms
governing shuttling of 
 
 
 
-catenin are quite complex and in-
volve a large protein encoded by the tumor suppressor gene
adenomatous polyposis coli implicated in transport of
 
 
 
-catenin out of the nucleus to cytoplasm for further degra-
dation (Henderson, 2000; Neufeld et al., 2000b; Rosin-
Arbesfeld et al., 2000). Adenomatous polyposis coli itself is a
shuttling protein and is exported out of the nucleus in a
CRM1-dependent manner (Henderson, 2000; Neufeld et
al., 2000a; Rosin-Arbesfeld et al., 2000). Shuttling of pro-
teins between different cellular compartments plays a ma-
jor role in the Wnt pathway. The regulated shuttling of
AHNAK in epithelial cells might play a role in a yet to be
identified signal transduction pathway. Due to its ability
to change subcellular localization quite rapidly, AHNAK
might be transmitting signals from the cell periphery to the
nucleus or even physically transferring proteins to the re-
quired locales within the cells.
An obvious question that arises from analysis of AHNAK
distribution in HeLa and MDCK cells is that extranuclear
localization of AHNAK might be related to an altered prolif-
eration rate of densely growing cultures. We have found that
not to be the case for dense HeLa cultures, but cessation of
proliferation occurs in MDCK cells with mature cell–cell
contacts (usually 
 
 
 
72 h after plating). This indicates that a
rather direct correlation exists between nuclear exclusion of
AHNAK in epithelial cells and formation of cell–cell con-
tacts, whereas potential links to proliferation rates remain to
be explored. However, it is possible that the plasma mem-
brane–anchored AHNAK is somehow involved in the even-
tual growth arrest of normal epithelial cells. The relationship
between localization of AHNAK and cell proliferation
promises to be complicated and cell type dependent. For ex-
ample, our unpublished data show that AHNAK is nuclear
in glioblastoma cell lines but predominantly cytoplasmic in
proliferating neuroblastoma cells. However, in terminally
differentiated neuroblastoma cells AHNAK translocates to
the nuclei and to the neuronal processes (unpublished data).
It is yet unclear whether relocalization of AHNAK in
growth-arrested neuroblastoma cells is a direct consequence
of proliferative quiescence induced by retinoic acid, or rather
a consequence of a dramatic change in cellular morphology
from an undifferentiated to a neuronal phenotype.
In conclusion, AHNAK is a new PKB phosphorylation
substrate whose subcellular localization, like that of several
other PKB targets, is subject to regulation by PKB phosphor-
ylation. All identified PKB substrates share one common fea-
ture: they play critical roles in most important pathways gov-
erning cell survival and proliferation and belong to different
classes of proteins ranging from transcription factors and
proapoptotic proteins to CDK inhibitors and metabolic reg-
ulators. Though the function of AHNAK remains a mystery,
its unusual structural features and unique flexible and highly
regulated localization patterns might indicate an important
role of this protein in key signal transduction processes.
 
Materials and methods
 
Cell culture
 
HeLa cells were maintained in high-glucose DME with 10% FCS. MDCK
cells were maintained in DME with 5% FCS. For transfections and immu-
nofluorescense, cells were plated on eight-well chamber slides at desired
densities, fixed 24 h after transfection, and processed. Transfections were
carried out using Fugene (Roche) according to the manufacturer’s proto-
col. Usually 200 ng of plasmids was transfected per well. Treatment before
fixing cells included LY290042 (Calbiochem) at 30 or 50 
 
 
 
M or LMB
(Sigma-Aldrich) at 20 ng/ml.
 
Plasmid constructs
 
EGFP and GST fusion constructs were generated using PCR with oligonu-
cleotides designed to amplify desired regions of AHNAK cDNA and intro-
duce restriction sites for subcloning into pEGFP.C1 (all COOH-terminal
constructs), pEGFP.N1 (the NH
 
2
 
 terminus of AHNAK), or pGEX.KG. Muta-
tions were introduced through whole-plasmid PCR with the Pfu Turbo
polymerase (Stratagene) using oligonucleotides with desired changes. The
starting plasmid was digested with Dpn1 before transformation of 
 
Esche-
richia coli
 
. All introduced amino acid substitutions were confirmed by se-
quence analysis. Expression of proteins of expected size from all constructs
was confirmed by transient transfection into HEK293 cells and Western
blot analysis of lysates with appropriate antibodies. 
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Cell staining
 
Cells in chamber slides were fixed in 4% buffered paraformaldehyde for
15 min, permealized in 0.1% Triton X-100 for 7 min, blocked in 2% BSA
for 30 min, and incubated with anti-AHNAK antibodies FEN (Shtivelman
and Bishop, 1993) or phosphospecific antibodies to AHNAK in 1% BSA for
1 h at room temperature. After PBS washes, cells were incubated with
Cy3-conjugated goat anti–rabbit antibodies (Jackson ImmunoResearch
Laboratory) and nuclei were counterstained with DAPI.
 
Purification of phosphospecific antibodies
 
Rabbits were immunized with phosphopeptide FKSKKPRHRSNpSFSDER
corresponding to positions 5524–5540 in the AHNAK amino acid se-
quence and synthesized at the Biomolecular Resource Facility of The Uni-
versity of California at San Francisco (San Francisco, CA). The phospho-
peptide was conjugated to maleimide-coupled BSA (Pierce Chemical Co.).
Antisera were passed three times through an affinity column of the non-
phosphorylated form of the immunizing peptide (SulfoLink; Pierce Chemi-
cal Co.). The bound antibodies were eluted each time to produce a frac-
tion recognizing both nonphosphorylated and phosphorylated forms of
AHNAK. The final flowthrough was then passed through a column of the
immunizing phosphopeptide. The retained antibodies were eluted, con-
centrated, and used for analyses in the presence of the nonphosphorylated
peptide to ensure specific detection of phosphoserine 5535.
 
Western blot analysis
 
Western blots for AHNAK were performed with protein extracts separated
on 4% polyacrylamide gels; blotted using Novagen/InVitrogene module,
incubated with appropriate antibodies and horseradish peroxidase–conju-
gated goat anti–rabbit antibodies (Dako), and developed using ECL (Amer-
sham Pharmacia Biotech).
 
Phosphorylation of AHNAK by PKB in vitro
 
0.2 
 
 
 
g of partially active glu-glu–tagged PKB purified from Sf9 cells
(Stokoe et al., 1997) was added to 0.5 
 
 
 
g of GST or GST fusion proteins in
a kinase buffer consisting of 20 mM Tris HCl, pH 7.5, 1 mM EDTA, 75 mM
NaCl, and 10 mM MgCl
 
2
 
.
 
 
 
20 
 
 
 
M ATP containing 5 
 
 
 
Ci 
 
[
 
 
 
-
 
32
 
P]ATP was
added to initiate phosphorylation in a total reaction volume of 20 
 
 
 
l. After
20 min, the reaction was terminated by the addition of 2
 
  
 
SDS sample
buffer, the samples separated by SDS-PAGE, and phosphorylation detected
by PhosphorImager analysis. GST-BAD (0.5 
 
 
 
g) was used as a positive
control for phosphorylation by PKB.
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